NTEC Announces Venture Alliance Partner Program
NTEC Announces Venture Alliance Partner Program
Featuring Ten Key VC Firms
from Around the U.S. Including Texas-Based Sevin Rosen and Santé
Ventures
(FRISCO, TEXAS / July 26, 2010) -
The North Texas Enterprise Center (NTEC), a nonprofit
organization dedicated to assisting MedTech and CleanTech start-up
companies, has announced the formation of their Venture Alliance
Partner Program (VAP). The VAP Program was created to enhance
start-up company deal visibility for local and out of state venture
capital funds, facilitate deal syndication among participating
partners and to provide increased emerging company access to
institutional investors.
"We recognized the intersection of need and opportunity and
decided to provide a solution in the form of our VAP Program," said
Larry Calton, Executive Director at NTEC. The VAP Program is
targeting venture capital firms, most of which are out of state,
that commit to spending from two days a month to two days per
quarter maintaining "office hours" at the NTEC facility in
Frisco. NTEC will help identify and screen companies and
coordinate meetings with the investors during their office hours at
the facility."
"For startup firms it is often difficult to get access to
capital. This program should make the process much more efficient
and serve both, the start-up community and the venture capital
community," said Dr. Hubert Zajicek, Senior Director at
NTEC.
NTEC has also partnered with Southern Methodist University (SMU)
to utilize business students to assist with due diligence and
market research on companies applying for VAP consideration.
Dallas-based Sevin Rosen Funds (SRF) was the first venture fund to
join the VAP Program, according to Jon Bayless, SRF General
Partner.
"SMU has long been committed to venture capital as a core
component of a healthy entrepreneurial environment, and partnering
with NTEC on the Venture Alliance fits perfectly with our goal of
being a top educational resource for future generations of private
equity executives and venture capitalists," said John F. Terry,
adjunct professor for the Caruth Institute for Entrepreneurship at
the Cox School of Business at SMU and founding board member of the
SMU MBA Venture Fund.
"The VAP Program launched by NTEC should be a valuable resource
to entrepreneurs starting businesses in North Texas. We are
pleased to partner with NTEC in this effort, and anticipate that
the VAP Program will help identify capable local entrepreneurs and
assist them in attracting venture capital from us and others,"
explained Bayless.
"The NTEC Venture Alliance Partner program is a great deal flow
resource for Chrysalis Ventures as we continue to actively invest
from our $175 million fund which closed in 2008," said Alan Ying of
Louisville, KY-based Chrysalis. "The focus on the medical
technology sector as it relates to healthcare technology services
is a great fit for our investment thesis of investing in
businesses that offer productivity-enhancing solutions to make the
delivery of healthcare more efficient."
Below are the venture capital firms that make up the NTEC
VAP:
ARBORETUM PARTNERS
Arboretum Ventures is an early-stage venture capital
firm specializing in the healthcare sector. It invests throughout
the United States, but with a special interest in the Midwest. More
than simply a financial resource, Arboretum Ventures is a
collaborative, value-added investor actively engaging its companies
in strategy, operations, recruiting, fundraising and exit
planning. Arboretum Ventures aims to transform young
companies into mature and thriving businesses that improve patient
outcomes and lower the cost of care, thereby generating superior
returns for the entrepreneurs and its investors. Founded in 2002
and headquartered in Ann Arbor, Michigan, Arboretum currently
manages approximately $97 million in capital. Market Place Building
/ 30 Detroit Street, Suite 301 / Ann Arbor, MI 48104 /
734.998.3688. www.arboretumvc.com.
BALLAST POINT VENTURES
Ballast Point Ventures is a venture capital firm
providing expansion capital to rapidly growing private companies
located primarily in the Southeast and Texas. Ballast Point
Ventures partners with talented and driven management teams to
achieve profitable long-term growth. It understands the importance
of making the right decisions for the long run, and it provides its
entrepreneur partners with extensive experience, critical
resources, valuable introductions and helpful insights as they
strive to build industry-leading companies. 880 Carillon Parkway /
St. Petersburg, FL 33716 / 727.567.1500. www.ballastpointventures.com.
CHRYSALIS VENTURES
Founded in 1993, Chrysalis Ventures manages one of
Mid-America's largest funds for early-stage and growth investments
with approximately $400 million under management. Focused on
partnering with entrepreneurs to build enduring businesses in
industries undergoing significant transformation, Chrysalis has
invested in over 65 companies primarily in the healthcare and
technology sectors. With headquarters in Louisville, KY, Chrysalis
has an office in Houston and has invested in companies in Dallas,
Austin and Houston, including its recent successful exit of
MedServe, a Houston-based provider of medical waste management
services to hospitals and clinics which was acquired by and became
a wholly-owned subsidiary of Stericycle, Inc.
(NASDAQ:SRCL) in December 2009. 101 South Fifth Street, Suite
1650 / Louisville, KY 40202 / 502.583.7644. www.chrysalisventures.com.
HERON
CAPITAL
Heron Capital is a venture capital fund dedicated to investing
in mid and growth stage companies focused on the life sciences,
including therapeutic medical devices, diagnostics and healthcare
services. The firm is advised by a world-renowned network of
scientists and physicians, as well as entrepreneurs and leaders of
national and multinational corporations. The mission of the Fund is
to identify and invest in companies with great commercial
potential, strong intellectual property and the highest quality
management. One Indiana Square / 211 North Pennsylvania
Street, Suite 2250 / Indianapolis, IN 46204 /
317.686.1950. www.heroncap.com.
H.I.G. BIOVENTURES
H.I.G. BioVentures invests in companies developing
innovative products for significant unmet medical needs in
therapeutics, medical device technology, specialty pharmaceuticals
and diagnostics. A natural extension of the broader H.I.G. Capital
platform, H.I.G. BioVentures invests across a broad range of stages
and leverages its team of seasoned senior investment professionals
who have over 75 combined years of experience in life sciences
investing, operations, business development, sales and marketing,
research management, financ, and technology development. Our
ability to leverage the broader H.I.G. infrastructure and resources
provides significant value to our portfolio companies and partners.
H.I.G. BioVentures is the life sciences venture capital affiliate
of H.I.G. Capital, a leading global private investment firm with
over $7.5 billion of capital under management and U.S. offices in
Atlanta, Boston, Miami, New York and San Francisco. 3050
Peachtree Road NW, Suite 360 / Atlanta, GA 30305 /
404.504.9333. www.higbio.com.
NORO-MOSELY PARTNERS
Since 1983, Noro-Moseley Partners has been a leading
Southeast venture capital firm bringing energy, connections and
domain expertise to the strongest entrepreneurs in the region. Over
the past 25 years, NMP has become an important part of the
Southeast's community of entrepreneurs and innovators. While
focused on generating significant returns for investors, NMP works
hard to be the entrepreneur's partner of choice in the
Southeast. NMP has invested in more than 160 promising
start-ups and early-growth-stage companies in the technology,
healthcare and business services industries. The firm has worked
with a wide range of entrepreneurs and has assembled an investment
team with the right mix of skills to assist entrepreneurs in
growing their companies. 9 North Parkway Square / Northside
Parkway NW /. Atlanta, Georgia 30327-3054 / 404.233.1966.
www.noromoseley.com.
PROLOG VENTURES
Prolog Ventures a venture capital firm specializing in
life sciences. Since its launch in 2001, it has supported more than
25 young companies. It invests in traditional healthcare
opportunities as well as emerging areas - such as nutrition,
wellness, and green technology - in which it has built one of the
largest portfolios in the country. 7701 Forsyth Blvd., Suite
1095 / St. Louis, MO 63105 / 314.743.2400. www.prologventures.com.
RIVER CITIES CAPITAL FUNDS
Founded in 1994, River Cities Capital Funds is one of
the most active and experienced venture funds investing in the
Midwest and Southeastern United States. The firm is currently
investing out of Fund IV closed in March 2008 at $120
million. River Cities Capital Funds has $390 million under
management and over 75 investments over fourteen years, and the
firm has established itself as a preferred partner among the
regional entrepreneurial and broader venture capital communities.
River Cities seeks to invest in high growth information technology
and healthcare companies that have a material customer base and are
nearing profitability. 221 East Fourth Street, Suite
2400 / Cincinnati, OH 45202-4151 \ 513.621.9700. www.rccf.com
SANTÉ VENTURES
Santé Ventures invests in early-stage life
science and healthcare companies. Experience has taught it that new
ventures are challenging and risky endeavors, and that the best
people can often make the crucial difference between success and
failure. With that in mind, Santé Ventures focuses on developing
lasting, well-aligned partnerships with exceptional entrepreneurs
and executives to build valuable companies. In addition to
capital, Santé Ventures provides deep healthcare domain expertise
and an extensive network of industry contacts and resources. Frost
Bank Tower / 401 Congress Avenue, Suite 2950 / Austin, Texas 78701
/ 512.721.1200. www.santeventures.com.
SEVIN ROSEN FUNDS
Sevin Rosen Funds is a top-tier venture capital firm
with a record of funding successful companies since 1981. The Sevin
Rosen partnership has consistently made early-stage investments in
pioneering technologies and companies with the potential to create
new markets. The partners' broad range of venture and operating
experiences in successful technology companies translates into a
sustained commitment and contribution to the development of the
ventures funded. The firm has Texas offices in Dallas and
Austin. Two Galleria Tower / 13445 Noel Road, Suite 1670 /
Dallas Texas 75240-5003 / 972.702.1100. www.srfunds.com.
About NTEC
The North Texas Enterprise Center (NTEC) is a
not-for-profit organization based in Frisco, Texas, that operates
as a business accelerator - providing a broad spectrum of services
and support to MedTech and CleanTech start-up companies.
NTEC, which was founded in 2002, has grown to become one of
the largest technology start-up accelerators in the South Central
U.S. NTEC's core mission is assisting entrepreneurs with the
challenging task of starting and expanding a new, technology-based
business venture. The target result of that mission is local
and regional economic development, new job creation and industry
diversification. For more information, please visit www.ntec-inc.org.